Inspire Medical announces publication of ADHERE data
Inspire Medical announced the publication of data from the first 508 Inspire therapy patients included in the 2,500-patient ADHERE registry. The data demonstrated that Inspire therapy is an effective treatment option with high patient satisfaction and low adverse events. These results represent the largest international data set for Inspire therapy generated to date. Key results highlighted in the publication included. Key results highlighted in the publication included: substantial reduction in OSA severity in response to Inspire therapy, patients used Inspire an average of 5.7 hours per night after 12 months and positive rates of patient-reported response to therapy experience.